The venture growth segment remains relatively untapped: Sameer Nath, Managing Partner, TrueScale Capital

Axio operates in a $12 billion global market that has seen limited innovation. It is delivering pathbreaking products across 40+ countries eliminating technology risk, and it has secured two US FDA and two EU CE approvals eliminating regulatory risk.

from The Financial Express https://ift.tt/3ETTyDf
https://ift.tt/eA8V8J Sudhir Chowdhary